ScholarIQanswers from OpenAlex & ORCID
Ricardo Blanco
ResearcherPublications, citations & collaboration network
Ricardo Blanco is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Ricardo Blanco have?
ScholarIQindexed works
Ricardo Blanco has 1,044 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ricardo Blanco have?
ScholarIQcitation count
Ricardo Blanco has 19,515 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Ricardo Blanco?
ScholarIQh-index
Ricardo Blanco has an h-index of 72 in OpenAlex.
What is the i10-index of Ricardo Blanco?
ScholarIQi10-index
Ricardo Blanco has an i10-index of 358 in OpenAlex.
What is the ORCID of Ricardo Blanco?
ScholarIQorcid
The ORCID for Ricardo Blanco is on the source record.
What is the OpenAlex record for Ricardo Blanco?
ScholarIQopenalex
The OpenAlex for Ricardo Blanco is on the source record.
What are the most-cited papers on Ricardo Blanco?
ScholarIQmost cited works
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
Gerd R Burmester, Ricardo Blanco, Christina Charles‐Schoeman, J. Wollenhaupt, Cristiano A. F. Zerbini, Birgitta Benda, David Gruben, Gene V. Wallenstein, Sriram Krishnaswami, Samuel H. Zwillich, Tamás Koncz, Koshika Soma, John Bradley, Charles A. Mebus
Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors
Dafna D. Gladman, William F. C. Rigby, Valderílio Feijó Azevedo, Frank Behrens, Ricardo Blanco, Andrzej Kaszuba, Elizabeth M. Kudlacz, Cunshan Wang, Sujatha Menon, Thijs Hendrikx, Keith S. Kanik
Henoch‐Schönlein purpura in adulthood and childhood. Two different expressions of the same syndrome
Ricardo Blanco, Víctor M. Martínez‐Taboada, Vicente Rodrı́guez-Valverde, Miguel García‐Fuentes, Miguel Á. González‐Gay
Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structu
Joel M. Kremer, Ricardo Blanco, Marek Brzosko, Rubén Burgos‐Vargas, Anne-Marie Halland, Emma Vernon, Petra Ambs, Roy Fleischmann
Permanent visual loss and cerebrovascular accidents in giant cell arteritis: Predictors and response to treatment
Miguel Á. González‐Gay, Ricardo Blanco, Vicente Rodrı́guez-Valverde, Víctor M. Martínez‐Taboada, Miguel Delgado‐Rodríguez, Manuel Figueroa, E. Uriarte